Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


The best advertising is free

Executive Summary

PhRMA defends "Pray for a Miracle" ad campaign in response to Sept. 20 letter from Generic Pharmaceutical Association (1"The Pink Sheet" Sept. 23, In Brief). "The ad accurately points out that the legislation you champion would reduce incentives for the discovery of new medicine," PhRMA President Alan Holmer told GPhA in a Sept. 24 letter. "Generic drugs will offer nothing to those patients whose chances for a cure would decline if that legislation were to pass"...

You may also be interested in...

PhRMA’s prayer is answered

Generic Pharmaceutical Association urges Pharmaceutical Research & Manufacturers of America to discontinue ad campaign entitled "Pray For A Miracle." Ad "shamelessly exploits the photograph of a critically ill child" and "serves no purpose in advancing the debate regarding Hatch/Waxman," GPhA says in Sept. 20 letter to PhRMA. Ad ran in the Washington Post Sept. 18...

FDA OK’s Insomnia Treatment Through Software Pre-Cert Program

Pear Therapeutics’ Somryst insomnia treatment tool has become the first FDA-cleared product that was reviewed through the agency’s Software Precertification Pilot Program.

Neuraxpharm Allies With Panaxia On Cannabis Portfolio

CNS specialist Neuraxpharm has struck a deal with Israel’s Panaxia to market medical cannabis products in Europe, starting in Germany.




Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts